Gráfico del Precio de Acciones UNCY
UNCY Precio
Unicycive Therapeutics Inc
$8.17
2.76%
$0.21
Al cierre: May 12, 16:00:00 GMT-4
$8.01
-1.95%
$-0.16
Mercado Posterior: May 12, 20:00:00 GMT-4
Atrás
Unicycive Therapeutics Inc (UNCY) Precio
Estadísticas clave
Cierre Anterior
$7.95
Precio de apertura
$8.01
Rango del día
$7.86 - $8.17
Rango de 52 semanas
$3.71 - $11
Volumen
420.5K
Volumen promedio
552.3K
Rendimiento de dividendos
--
EPS (TTM)
-2.97
Cap. de mercado
$202.1M
¿Qué es UNCY?
Unicycive Therapeutics, Inc. is a biotechnology company, which engages in developing novel treatments for kidney diseases. The company is headquartered in Los Altos, California and currently employs 21 full-time employees. The company went IPO on 2021-06-17. The firm's lead drug candidate, oxylanthanum carbonate (OLC), is an investigational phosphate binding agent being developed for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis. Its second asset, UNI-494, is a patent-protected new chemical entity in clinical development for the treatment of conditions related to acute kidney injury.
Características
© 2026 Edgen impulsado por
